Hearing Loss Products and Services
Advertise on Hearing Loss Web
Search This Site or the Web

Free Email Newsletter

Jobs, Jobs, Jobs

Hearing Loss Web Banner
Discussion Forum
Hearing Loss Events
Last Update: Nov 8

 

Home

About Us

Search

New to Hearing Loss?
In the News

Discussion Forum

HOH-LD-News

Advertise

Contact Us

Glossary

Events

 

Issues

Access

Oral Communications

Emergency Planning

Employment

Family

Hearing Aid Affordability

Identity

Law Enforcement

Psychological

Services

 

Medical

Audiology

Causes

Cures

Meniere's Disease

Tinnitus

Local Resources and Events
 
Employment Opportunities
 
Education Opportunities
 

Hearing Loss Products and Services

Advocates and Legal
Alerting Devices
Assistive Listening Devices
Business Services

Captioning

Financial Services
General Stores

Government

Health Products and Services
Hearing Aids
Hearing Aid Accessories
Hearing Aid Batteries
Hearing Aid Maintenance
Hearing Aid Repair
Hearing Dogs
Hearing Loss Organizations
Hints and Tips
Kids' Stuff
Medical Products and Services
Pagers

Publications

Relay Service
Sign Language Materials
Telecommunications Distribution Program

Telephones

Travel

TTYs (TDDs)

TTY Repairs

Two-Way Pagers

Technology

Alerting Devices

Assistive Listening Devices

Cochlear Implants

Hearing Aids

Speech Recognition

Telephones

Two Way Pagers

TTYs (TDDs)

Visual Communications

Links

Growth Factors May Boost CI Function

Editor: Scientists have discovered that injecting growth factors into an animal's ears before cochlear implant (CI) surgery increases CI performance. The story is from Newsday (http://www.newsday.com/news/health/ny-dstop2621104mar12.story) via bhNEWS.

~~~~~~~~~~~~~~~~~~~

Doses of growth factors may boost function of implants
By Robert Cooke STAFF WRITER

March 12, 2002

MODERN HEARING DEVICES called cochlear implants may work far better if growth factors are used first to reawaken damaged nerves, scientists report.

Cochlear implants - hearing devices that directly stimulate the auditory nerve - are now widely used to restore at least crude hearing in people who are not helped by even the best hearing aids. The implant device's performance is sometimes hampered, however, because nerves serving the ear have begun to fail after years of not being used.

Trying to see if resurrecting nerve function is possible, neuroscientist Josef Miller and his colleagues implanted tiny pumps into the ears of deafened animals. The pumps released constant low doses of nerve growth factors for a month before the animals were given cochlear implants. The treatment, tried only in laboratory animals, succeeded.

Use of the nerve growth factors not only increased the survival of neurons in the animals' auditory nerve, Miller and his colleagues reported, but it "significantly enhanced the functional responsiveness" of the animals' hearing once they were set up with cochlear implant devices.

"The animal work looks terrific, and it's supported by a variety of other studies" that suggest it's likely to work when applied to humans, Miller said in an interview. "Human auditory nerve cells are sensitive to these growth factors," so they should respond properly, he added.

The slowdown or loss of nerve function occurs because as sensory cells in the ear die, they stop producing growth factors that the auditory nerve cells need to stay healthy. "But it's not like muscle atrophy from lack of use," Miller explained. "With the death of cells, there is a lack of the survival factors that the cells and the central nervous system normally provide," And, given time, the auditory nerve cells begin to die away.

Hearing impairment - including deafness - "is the most frequent disability in industrialized countries," the research team wrote in the Proceedings of the National Academy of Sciences. Loud machinery, blaring music, drug use and infectious diseases all contribute to what can be considered a modern epidemic of hearing loss, approaching deafness. Hearing ability also wanes with age as the number of so-called hair cells in the cochlea decreases.

More than 40,000 cochlear implants are now in use worldwide. Although the battery-powered implants do not completely restore normal hearing, they do allow deaf people to recognize numerous sounds. Some patients can even understand much of what is said to them.

"They're doing remarkably well," Miller said. "The majority of them can talk" and hear on the telephone because their cochlear implants work so well.

Maurice Miller, professor of audiology at New York University, said that Josef Miller's results are very important. "It's on the threshold of a breakthrough in the treatment of sensory deafness in humans. He's an outstanding scientist, and this is quality stuff." (The two Millers are not related.)

In a report, Josef Miller and coworkers from Sweden and Japan predicted their results will "have great clinical importance for the treatment of deaf patients with cochlear implants." Josef Miller and one colleague, Richard Altschuler, are both at the Kresge Hearing Research Institute at the University of Michigan.

The cochlea, a snail-shaped organ in the inner ear, is filled with fluid and lined with hair cells. The task of these highly specialized cells is to convert the mechanical vibrations of sound into electrical impulses that are sent to the brain.

As the hair cells die off - either gradually or suddenly - the nerves carrying electric impulses are left unemployed. Also, Josef Miller said, because growth factors released by the hair cells and other cells are missing, the auditory nerve cells begin to deteriorate.

The technology for delivering small, constant doses of the growth factors already exists. What might pose problems, Josef Miller said, is the danger of side effects. When the same growth factors - called neurotrophic factors - are used for other treatments, the side effects "are enormous. Most trials have been discontinued because of the side effects," which include nervousness, sleeplessness, digestive disorders and impotence. The growth factors were being tested against neurological maladies, including Parkinson's disease and Lou Gehrig's disease.

Josef Miller and his colleagues hope that side effects can be avoided, or minimized, by confining the growth factors to the inner ear. "We're in a potentially unique situation, because it [the cochlea] is so encased in bone, and there are very few channels for it to get into other parts of the body," he explained.

If the research progresses as well as hoped, "we have a goal of being able to begin in two years" with tests in humans, Josef Miller added.

The growth factor treatment would not be useful for people who wear conventional hearing aids, which work by sending amplified sound into the ear to stimulate any hair cells that remain. Cochlear implants are aimed at persons who have lost almost all of their hair cells and need devices that bypass the hair cells and stimulate the nerves directly. Tiny electronic probes are inserted into the cochlea, where they interact with the auditory nerve. By this method, even if the hair cells have all died, signals can still enter the brain.

After almost 40 years of research and development, the cochlear implant "now provides significant speech understanding, with a score for everyday sentence understanding of about 80 percent, without lip reading, in the majority of patients," the research team wrote.

How the Implant Works

1. Microphone picks up sound and converts it to electrical energy that is amplified and filtered by a small processor that can be tucked into clothing or worn on a belt.

2. Amplified signal sent to external transmitter that converts it to magnetic energy.

3. Magnetic signal sent to internal receiver implanted under skin.

4. Signal travels from internal receiver to inner ear on a platinum electrode.

5. Current flowing between active electrode in inner ear and nearby ground electrode stimulates nerve fibers in a way the brain interprets as sound.